← All news

FROM THE NEWS FEED

Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training

2026-09-10 • Psychedelic Invest

Article summary

Fluence, a leading provider of professional education in psychedelic therapy, today announced that it has been selected by Compass Pathways plc (Nasdaq: CMPS) as a recipient of its U.S. healthcare…

Continue to the original publication for the complete article.